Logo SEFAC
Farm Comunitarios. 16(4):24-35. doi: 10.33620/FC.2173-9218.(2024).24

Analysis and categorization of pharmacotherapeutic queries received at a Valencia Drug Information Center

Gutiérrez-Igual S1, 2, Lucas-Domínguez R3, 4, 5, Romero Crespo I1, Montesinos M2, 6
1. Official College of Pharmacists of Valencia (MICOF), Valencia, Spain. 2. Department of Pharmacology. University of Valencia (UV). 3. Department of History of Science and Documentation. Faculty of Medicine and Dentistry. University of Valencia (UV). 4. UISYS- Unit associated with the Interuniversity Institute for Advanced Research on Science and University Evaluation (INAECO). UC3M-UAM3. 5. CIBERONC, Valencia. Spain. 6. Interuniversity Institute of Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia (UPV) and University of Valencia (UV), Spain.
Gutiérrez-Igual S, Lucas-Domínguez R, Romero I, Montesinos M. Analysis and categorization of pharmacotherapeutic queries received at a Valencia Drug Information Center. Farm Comunitarios. 16(4):24-35. doi: 10.33620/FC.2173-9218.(2024).24
Abstract : 

Introduction: Drug Information Services (DIS) act as a source of technical and scientific information of drugs and medical devices, promoting their rational use.

Objectives: To analyze and classify, according to standardized criteria, the pharmacotherapeutic queries, therapeutic groups, and drugs most frequently consulted at the DIS of the Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF).

Methodology: An ambispective and cross-sectional observational study was conducted from June 1, 2021, to June 1, 2022. A total of 445 inquiries made by pharmacists from the province of Valencia were registered and analyzed, collecting the following data: drug, ATC-4 therapeutic group, and pharmacotherapeutic category of the query.

Results: The most frequently consulted categories were commercialization and safety, with Proton Pump Inhibitors (PPIs, A02BC) and Vitamin K Antagonists (VKAs, B01AA) being the most consulted pharmacological groups, accounting for 2.7% and 2.3% of the total inquiries respectively. Regarding classification, 90,0% of the inquiries about acenocoumarol were about drug interactions, while 33.3% of the inquiries about PPIs were related to commercialization.

Conclusions: The analysis of the inquiries received has made possible to identify the therapeutic groups, drugs and pharmacotherapeutic categories that generate the highest number of inquiries. This information is valuable for improving the efficiency of responses at the DIS, providing uniformity, and reducing errors. Additionally, it provides a comprehensive database that facilitates the standardized integration of information.

Keywords : 
Drug Information Service, Classification, Proton Pump Inhibitors, Drug Interactions.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/

Share

-

Manual for authors

Journal Information